Table S2. Clinical features of 20 collected ccRCC patients including: 2 G1; 7 G2; 8 G3 and 3 G4 processed by RPPA. (PDF 488 kb
Figure S6. (A) Freshly dissociated tissues maintained for one week in serum-free stem cell-isolating...
Main characteristics of patients affected by clear cell Renal Cell Carcinoma (ccRCC) and renal oncoc...
Additional file 1: Table S1. Basic information of sample cohort. Table S2. Data quality control metr...
Table S4. Clinical features of 30 collected ccRCC patients and used for in vivo models including: 3 ...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Figure S2. (A) Hematoxylin and Eosin (H&E) and CD31 staining of formalin-fixed and paraffin- embedde...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Differentially expressed genes between matched tumor tissue and VHLmut cultures. (XLSX 1.05 mb
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Table S3. List of total and phosphorylated proteins analyzed by RPPA. In blue, positively expressed ...
Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...
Figure S10. (A) Kaplan-Meier curve for the Disease Free Survival (DFS) in the engrafted (Engraf) and...
Figure S7. (A) Two-way unsupervised hierarchical clustering of RPPA data of 2 G1, 7 G2, 8 G3, and 3 ...
Figure S2.ROC analysis of Heng’s risk model alone and expanded with CCR7 continuous IOD score on pat...
Figure S4. (A) Fresh dissociated tissues maintained for three days in serum-free stem cell-isolating...
Figure S6. (A) Freshly dissociated tissues maintained for one week in serum-free stem cell-isolating...
Main characteristics of patients affected by clear cell Renal Cell Carcinoma (ccRCC) and renal oncoc...
Additional file 1: Table S1. Basic information of sample cohort. Table S2. Data quality control metr...
Table S4. Clinical features of 30 collected ccRCC patients and used for in vivo models including: 3 ...
Figure S1. (A) (PANEL1) Table of 1286 ccRCC patient distribution: 1013 tumor free patients at 36 mon...
Figure S2. (A) Hematoxylin and Eosin (H&E) and CD31 staining of formalin-fixed and paraffin- embedde...
Figure S8. (A) Representative images of Western blot analysis of pAKT S473 and pERK T202/Y204 protei...
Differentially expressed genes between matched tumor tissue and VHLmut cultures. (XLSX 1.05 mb
Figure S3 (A) RPPA-TCGA elaboration of E-Cadherin and Fibronectin expressions. Data were obtained fr...
Table S3. List of total and phosphorylated proteins analyzed by RPPA. In blue, positively expressed ...
Figure S1. Flow chart of included patients. Table S2. Table resuming patients âcharacteristics. Ta...
Figure S10. (A) Kaplan-Meier curve for the Disease Free Survival (DFS) in the engrafted (Engraf) and...
Figure S7. (A) Two-way unsupervised hierarchical clustering of RPPA data of 2 G1, 7 G2, 8 G3, and 3 ...
Figure S2.ROC analysis of Heng’s risk model alone and expanded with CCR7 continuous IOD score on pat...
Figure S4. (A) Fresh dissociated tissues maintained for three days in serum-free stem cell-isolating...
Figure S6. (A) Freshly dissociated tissues maintained for one week in serum-free stem cell-isolating...
Main characteristics of patients affected by clear cell Renal Cell Carcinoma (ccRCC) and renal oncoc...
Additional file 1: Table S1. Basic information of sample cohort. Table S2. Data quality control metr...